Skip to main content

Table 1 CD22 ADC/recombinant immunotoxin structures

From: Targeting CD22 for B-cell hematologic malignancies

ADC/recombinant immunotoxin

Anti-CD22 antibody

Cytotoxic payload

Linker

Disease

BL22

RFB4 dsFv

Pseudomonas exotoxin A (PE38)

mc-VC-PABC (enzyme cleavable)

R/R HCL

Moxetumomab pasudotox/HA22

RFB4 dsFv (SSY-THW)

Pseudomonas exotoxin A (PE38)

mc-VC-PABC (enzyme cleavable)

R/R B-cell HCL

Pinatuzumab vedotin

Hu10F4 antibody

Monomethyl auristatin E

mc-VC-PABC (enzyme cleavable)

R/R B-cell NHL

Anti-CD22-NMS249

Hu10F4 antibody

PNU-159682

mc-VC-PABC (enzyme cleavable)

R/R B-cell NHL

Anti-CD22-(LC:K149C)-SN36248

Hu10F4 antibody

SN36248 × 2

maleimide linker (uncleavable)

B-cell NHL

Inotuzumab ozogamicin

G544 antibody

Calicheamicin (Calich-DMH)

hydrazone (acid-labile linker)

R/R B-ALL

  1. dsFv disulfide-stabilized Fv fragment, R/R relapsed or refractory, HCL hairy cell leukemia, NHL non-Hodgkin lymphoma, ALL acute lymphoplastic leukemia